Structure | Compound Name | Standard Type | Standard Values (in nM) |
|---|---|---|---|
| Ruxolitinib | IC50 | 100.0 [1] | |
| CID 53344620 | IC50 | 27.0 [1] | |
| [2-[6-(2-Ethyl-5-fluoro-4-hydroxyphenyl)-1H-indazol-3-yl]-3,4,6,7-tetrahydroimidazo[4,5-c]pyridin-5-yl]-(5-piperidin-1-ylpyrazin-2-yl)methanone | IC50 | 70.3 [1] | |
| 4-[3-(1h-Benzimidazol-2-Yl)-1h-Indazol-6-Yl]-3-Ethylphenol | IC50 | 10.5 [1] | |
| 6-(2-Ethyl-4-Hydroxyphenyl)-1h-Indazole-3-Carboxamide | IC50 | 19.1 [1] | |
MLA | "Quest Database™ Janus Kinase (JAK) Inhibitors (IC50, Ki)." AAT Bioquest, Inc., 20 Jan. 2026, https://www.aatbio.com/data-sets/janus-kinase-jak-inhibitors-ic50-ki. | |
APA | AAT Bioquest, Inc. (2026, January 20). Quest Database™ Janus Kinase (JAK) Inhibitors (IC50, Ki). AAT Bioquest. https://www.aatbio.com/data-sets/janus-kinase-jak-inhibitors-ic50-ki. | |
| BibTeX | EndNote | RefMan |